METASTATIC BREAST CANCER
Clinical trials for METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New breast cancer drug trial halted early after only 11 patients
Disease control TerminatedThis study tested a new drug called BDC-1001, alone or with another drug (pertuzumab), in people with advanced HER2-positive breast cancer who had already tried other treatments including trastuzumab deruxtecan. The goal was to see if the drug could shrink tumors. However, the st…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Promising breast cancer drug trial halted after only 2 patients enrolled
Disease control TerminatedThis study aimed to see if the drug trastuzumab deruxtecan (T-DXd) could help people with a certain type of advanced breast cancer (HER2-positive) that had stopped responding to initial therapy. The plan was to treat 41 participants, but the trial was stopped early after only 2 p…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Experimental breast cancer drug trial halted early
Disease control TerminatedThis study tested the drug ixabepilone in 13 people with advanced breast cancer that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow the disease. The trial was terminated early, so results are limited.
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Experimental FGFR drug fails to reach goal in metastatic breast cancer trial
Disease control TerminatedThis study tested a drug called futibatinib (TAS-120) in people with advanced breast cancer that has spread and has specific FGFR gene changes. The drug was given alone or with hormone therapy. The trial was stopped early, and results were not fully reported. It involved 64 adult…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Scientists spy on immune system in advanced breast cancer
Knowledge-focused TerminatedThis study looked at immune cells in the blood and tumors of people with advanced breast cancer that has spread. The goal was to measure and understand these cells, not to test a new treatment. About 32 patients and some healthy volunteers provided samples over time. The study wa…
Matched conditions: METASTATIC BREAST CANCER
Sponsor: Spanish Breast Cancer Research Group • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC